🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
Prospective, multi-center, randomized, open label comparative Phase III stu...
Status
Recruiting
Location
University Clinic Ulm
Start Date
2025-04-22
Trial ID
NCT06643585
Treatments Being Tested
This study is phase II, open label, clinical trial to determine the efficac...
Status
Enrolling By Invitation
Location
Yonsei Severance Hospital
Start Date
2020-10-28
Trial ID
NCT04361370
Treatments Being Tested
This phase II/III trial compares the effect of the combination treatment wi...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-03-30
Trial ID
NCT05432791
This is a Phase 1 study to assess the safety and clinical activity of RO762...
Status
Completed
Location
University of California Irvine Medical Center
Start Date
2021-08-26
Trial ID
NCT05240898
Treatments Being Tested
The purpose of this research study is to evaluate the effectiveness of usin...
Status
Active Not Recruiting
Location
Indiana University Simon Comprehensive Cancer Center
Start Date
2022-09-02
Trial ID
NCT05366166
Treatments Being Tested
This randomized phase II trial studies how well cediranib maleate and olapa...
Status
Active Not Recruiting
Location
UC San Diego Moores Cancer Center
Start Date
2017-12-07
Trial ID
NCT02974621
Treatments Being Tested
This is a Phase III randomised, double-blind, multi-centre study to evaluat...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-01-04
Trial ID
NCT03737643
Treatments Being Tested
This phase III trial compares the effect of olaparib for one year versus tw...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2025-03-12
Trial ID
NCT06580314
Treatments Being Tested
This ComboMATCH patient screening trial is the gateway to a coordinated set...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-04-07
Trial ID
NCT05564377
Treatments Being Tested